Provider review · Published September 29, 2026 · Updated September 29, 2026

Duke Health ED consultations: where primary care and specialist review meet

The published pathway distinguishes an initial concern, reassessment after medication failure and referrals for contributing conditions.

Editorial document research · How we use sources

Duke Health describes erectile-dysfunction care as part of a wider sexual-health service. Its account is particularly useful for understanding why the first conversation and a specialist reassessment may have different purposes. Someone arriving with an unresolved concern does not necessarily need the same discussion as someone reviewing an earlier treatment.

Reviewed September 29, 2026, this article examines Duke’s service descriptions and the Raleigh clinic record. It does not establish individual eligibility, appointment availability or the outcome of a referral. The emphasis is on what the published pathway says about responsibility and what still needs to be agreed in actual care.

In this article

Keep this question in view

Duke confirms actual ED care and conditional specialist coordination. Its descriptions do not establish a personal test sequence, exact prescription or completed referral.

Recognize the distinction Duke makes

Duke’s male sexual-dysfunction page points people who have not tried ED medicines toward primary care and describes urologic help when medicines have failed. That is Duke’s published account of its pathway. It should not be converted into a diagnosis, a requirement to try a medicine independently or a universal rule for every patient.

The care-pathways comparison considers why different consultation settings have different roles. A specialist visit may be about revisiting an explanation, reviewing previous experience or considering unresolved findings. The public description does not decide which purpose applies to a reader, and a medication history alone cannot answer the question.

Separate the symptom from nearby conditions

The Duke service covers ED alongside ejaculation disorders and Peyronie’s disease. Those subjects share a clinical setting but retain different assessment and treatment questions. In particular, a description of treatment directed at Peyronie’s scarring should not be recast as an ED prescription pathway.

The first-appointment guide encourages a straightforward description of what has changed. Distinguishing erection difficulty from pain, curvature or ejaculation concerns helps avoid importing the wrong explanation from a broad service page. It does not require the patient to diagnose the condition beforehand. Duke’s range of services confirms relevant expertise without proving which part of that range a particular consultation will use.

The Raleigh record adds a clinical setting

Duke Urology of Raleigh explicitly includes ED among male sexual-health conditions it treats. The clinic also describes screening for underlying health problems and arranging referrals when needed. This supports a real clinical-service role, rather than an assumption based only on general educational material.

The record is specific to that clinic and should not be treated as a promise that every location offers the same encounter. The UCLA consultation review examines another confirmed service whose public workflow detail is limited. In both cases, naming a clinic establishes a place in the care system, while the individual examination, testing and continuity arrangements still require clarification.

Existing medicines deserve their own review

Duke states that current medicines are considered as possible contributors to ED. This is a reason to bring accurate information from all relevant prescribers. It is not evidence that a medicine has caused an individual’s symptoms or that the reviewing clinician can resolve the issue without the other treating professional.

NIDDK keeps medicine changes within professional discussion and warns against stopping products independently. Our interaction guide explains why occasional products also matter. The goal is a shared understanding of the actual record, not a shortened list that makes a requested ED prescription appear easier to issue.

A referral needs an identified reason

The Duke page describes referrals to specialties such as cardiology, sleep medicine, neurology and endocrinology when a medical condition is related to the sexual concern. It also describes work with cancer specialists. These are conditional clinical connections, not a standard itinerary through every department.

The Cleveland consultation review considers another institution’s account of contacting related specialists. Neither description proves that a patient’s referral has been accepted or that records have arrived. A useful handoff explains the question another professional is being asked to address and who will bring the answer back into the ED assessment, without relying on a general promise of coordination.

Do not mistake a service list for a prescription record

The Raleigh service description and broader Duke page support clinical evaluation and treatment. They do not identify a reader’s finished product, dispensing pharmacy or individualized instructions. The presence of surgical and nonsurgical options likewise does not establish that any particular one is appropriate.

If the consultation proposes treatment, the explanation should concern the actual option and the remaining uncertainties. A previous medicine’s name is relevant history rather than proof that the same preparation will be used again. This review does not infer a compounded formula, a route of administration or a treatment sequence from the institution’s broad range of sexual-health services.

Follow-up is a responsibility to clarify

The Raleigh page describes follow-up in its wider urologic practice, but does not publish a universal ED review schedule or allocate every later question between primary care and urology. That limited detail does not establish that ongoing review is absent. It identifies something the individual plan should make clear.

The follow-up guide explains why new medicines, unwanted effects and benefit belong in later clinical discussion. For Duke’s published pathway, a particularly useful question is whether primary care or the specialist will handle that discussion after assessment. A general referral statement cannot substitute for an agreed responsibility in the patient’s actual record.

Source documents

Provider documents establish what is advertised. Clinical and regulatory documents have different roles and do not independently verify the provider’s actual care.

Duke Health — Male Sexual DysfunctionOfficial clinical-service description, internally reviewed April 23, 2024. Primary-care and specialist roles are described; ED, ejaculation disorders and Peyronie’s care retain distinct contexts. · Checked 2026-09-29
Duke Health — Duke Urology of RaleighOfficial clinic record listing ED care, underlying-health assessment and conditional referrals. General urologic follow-up wording does not establish an ED review calendar. · Checked 2026-09-29
NIDDK — Treatment for Erectile DysfunctionFederal patient information last reviewed October 2024. Underlying-cause uncertainty and clinician-led medicine review are general context, not evidence of personal suitability or an institution’s exact workflow. · Checked 2026-09-29